Merck | Home
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Who we are - Merck.com
Merck aspires to be the premier research-intensive biopharmaceutical company in the world. Learn about our commitment to save and improve lives.
Discover Job Opportunities at Merck | Merck Careers
Explore current job opportunities at Merck. Learn more about careers in Business Support, Clinical, Engineering, Information Technology, Research & Development, Manufacturing and …
Company fact sheet - Merck.com
Dec 31, 2023 · Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. …
Products list - Merck.com
For information about Merck’s products and services including the reporting of an Adverse Event or Product Quality Complaint with a specific Merck product, please call the Merck National …
Our Q3 2024 financial results - Merck.com
Oct 31, 2024 · Merck’s Q3 2024 financial results represent strong progress across the business and our diverse pipeline. Our company announced worldwide sales of $16.7 billion, an …
Research - Merck.com
At Merck, we follow the science. Learn about Merck's research and products by getting to know the science, strategy and brains behind the innovations.
Contact us - Merck.com
Merck's U.S. headquarters, worldwide office, adverse event, investors, media, supplies and animal health contact information.
Merck Announces Third-Quarter 2024 Financial Results
Oct 31, 2024 · Merck now expects its full-year non-GAAP effective income tax rate to be between 16.0% and 17.0%, which includes an unfavorable impact related to the one-time charge …
Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating …
Nov 25, 2024 · RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today positive topline results from the …